Literature DB >> 25287992

Diet-induced obesity promotes a myeloma-like condition in vivo.

S T Lwin1, S W Z Olechnowicz2, J A Fowler3, C M Edwards1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25287992     DOI： 10.1038/leu.2014.295

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.

Authors:  Ola Landgren; S Vincent Rajkumar; Ruth M Pfeiffer; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Qiuyin Cai; Lynn R Goldin; Neil E Caporaso; Joseph F Fraumeni; William J Blot; Lisa B Signorello
Journal:  Blood       Date:  2010-04-26       Impact factor: 22.113

2.  Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

3.  Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.

Authors:  Jessica A Fowler; Gregory R Mundy; Seint T Lwin; Claire M Edwards
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

4.  The influence of genetic background on the expression of the obese (Ob) gene in the mouse.

Authors:  D L Coleman; K P Hummel
Journal:  Diabetologia       Date:  1973-08       Impact factor: 10.122

5.  Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study.

Authors:  Jonathan N Hofmann; Steven C Moore; Unhee Lim; Yikyung Park; Dalsu Baris; Albert R Hollenbeck; Charles E Matthews; Todd M Gibson; Patricia Hartge; Mark P Purdue
Journal:  Am J Epidemiol       Date:  2013-03-29       Impact factor: 4.897

6.  Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

Authors:  Alvin C Ng; Sundeep Khosla; Natthinee Charatcharoenwitthaya; Shaji K Kumar; Sara J Achenbach; Margaret F Holets; Louise K McCready; L Joseph Melton; Robert A Kyle; S Vincent Rajkumar; Matthew T Drake
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

7.  Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.

Authors:  Jessica A Fowler; Seint T Lwin; Matthew T Drake; James R Edwards; Robert A Kyle; Gregory R Mundy; Claire M Edwards
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

8.  Influence of body mass index on survival in veterans with multiple myeloma.

Authors:  Tracey S Beason; Su-Hsin Chang; Kristen M Sanfilippo; Suhong Luo; Graham A Colditz; Ravi Vij; Michael H Tomasson; John F Dipersio; Keith Stockerl-Goldstein; Arun Ganti; Tanya Wildes; Kenneth R Carson
Journal:  Oncologist       Date:  2013-09-18

Review 9.  The skinny on obesity and plasma cell myeloma: a review of the literature.

Authors:  K R Carson; M L Bates; M H Tomasson
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

10.  Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.

Authors:  F Murphy; M E Kroll; K Pirie; G Reeves; J Green; V Beral
Journal:  Br J Cancer       Date:  2013-05-02       Impact factor: 7.640
View more
  31 in total

1.  Preclinical animal models of multiple myeloma.

Authors:  Seint T Lwin; Claire M Edwards; Rebecca Silbermann
Journal:  Bonekey Rep       Date:  2016-02-03

Review 2.  MGUS to myeloma: a mysterious gammopathy of underexplored significance.

Authors:  Madhav V Dhodapkar
Journal:  Blood       Date:  2016-10-13       Impact factor: 22.113

Review 3.  The emerging role of bone marrow adipose tissue in bone health and dysfunction.

Authors:  Thomas H Ambrosi; Tim J Schulz
Journal:  J Mol Med (Berl)       Date:  2017-11-03       Impact factor: 4.599

4.  Obesity and neoplasms of lymphohematopoietic cells.

Authors:  Marshall A Lichtman
Journal:  Blood Adv       Date:  2016-11-22

Review 5.  Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.

Authors:  G Shay; L Hazlehurst; C C Lynch
Journal:  J Mol Med (Berl)       Date:  2015-10-01       Impact factor: 4.599

6.  Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.

Authors:  Shiny Nair; Andrew R Branagan; Jun Liu; Chandra Sekhar Boddupalli; Pramod K Mistry; Madhav V Dhodapkar
Journal:  N Engl J Med       Date:  2016-02-11       Impact factor: 91.245

7.  Connecting Bone and Fat: The Potential Role for Sclerostin.

Authors:  Heather Fairfield; Clifford J Rosen; Michaela R Reagan
Journal:  Curr Mol Biol Rep       Date:  2017-04-18

8.  Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).

Authors:  Brenda M Birmann; Gabriella Andreotti; Anneclaire J De Roos; Nicola J Camp; Brian C H Chiu; John J Spinelli; Nikolaus Becker; Véronique Benhaim-Luzon; Parveen Bhatti; Paolo Boffetta; Paul Brennan; Elizabeth E Brown; Pierluigi Cocco; Laura Costas; Wendy Cozen; Silvia de Sanjosé; Lenka Foretová; Graham G Giles; Marc Maynadié; Kirsten Moysich; Alexandra Nieters; Anthony Staines; Guido Tricot; Dennis Weisenburger; Yawei Zhang; Dalsu Baris; Mark P Purdue
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-02-21       Impact factor: 4.254

Review 9.  Myeloma and Bone Disease.

Authors:  Cristina Panaroni; Andrew J Yee; Noopur S Raje
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

10.  Abdominal adipose tissue in MGUS and multiple myeloma.

Authors:  Joyce Veld; Elizabeth K O'Donnell; Michaela R Reagan; Andrew J Yee; Martin Torriani; Clifford J Rosen; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2016-06-25       Impact factor: 2.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.